erythropoietin biosimilar (AfriVax)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameerythropoietin biosimilar (AfriVax)
Drug Alias Nameerythropoietin
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Biosimilar
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAfriVax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAfriVax Inc
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A